James Sidoti
Stock Analyst at Sidoti & Co.
(2.82)
# 1,497
Out of 5,176 analysts
8
Total ratings
66.67%
Success rate
60.05%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $19.19 | +45.91% | 3 | Aug 5, 2025 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $150 | $1.97 | +7,514.21% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $111.08 | -69.39% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $14.56 | +318.96% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $19.19
Upside: +45.91%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $150
Current: $1.97
Upside: +7,514.21%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $111.08
Upside: -69.39%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $14.56
Upside: +318.96%